If you’re dealing with persistent facial redness due to rosacea, you’re not alone. Studies show that topical treatments like metronidazole, ivermectin and potassium azeloyl diglycinate can help with the inflammatory bumps of rosacea, but are less effective when it comes to the persistent redness that lingers even after the lesions have healed, or persistent redness alone, which is the most common presentation for rosacea.
Enter Oxymetazoline— part of our new Calm AM + PM duo – formulated to help control rosacea and manage persistent redness from rosacea. Of course, if you have rosacea, you’ll already know that medical treatment is only part of the story – the right supporting skincare and skincare application techniques, proper UV and Visible Light protection, and trigger identification and management are part and parcel of rosacea management.
Our clinical support team are here to help our patients with evidence-based advice on these topics and personalised recommendations.
How Does Oxymetazoline Work?
Oxymetazoline was originally developed in 1961 as a nasal decongestant. It targets specific receptors on blood vessels known as α1-adrenergic receptors. By activating these receptors, oxymetazoline tightens the vessels, making them less visible, and helping to reduce the persistent redness associated with rosacea. Unlike similar medications, patients also experience less ‘rebound’ redness after the effects wear off.
Oxymetazoline not only helps to decrease redness but also has anti-inflammatory properties, which helps further reduce the overall inflammation and redness in rosacea-affected areas.
And the good news is that, if you are an appropriate candidate for Oxymetazoline treatment*, it can be used long term as part of a rosacea maintenance plan.
*Please book a video consultation with one of our doctors for a full assessment. A treatment plan will be discussed if you are suitable for remote, prescription skincare treatment. Any medical treatment carries risks and not everyone will be suitable for Qr8 treatment. Individual results will vary and are not guaranteed.
WOULD YOU LIKE TO CHAT TO ONE OF OUR FRIENDLY DOCTORS ABOUT YOUR SKIN CONDITION?
CLICK HERE TO BOOK A CONSULT WITH OUR EXPERIENCED MEDICAL TEAM.
REFERENCES
- Liu F, Zhou Q, Wang H, Fu H, Li Y, Tao M, Luo H, Cao Y. Efficacy and safety of oxymetazoline for the treatment of rosacea: A meta-analysis. J Cosmet Dermatol. 2023 Sep;22(9):2408-2419. PMID: 37128814.
- Draelos ZD, Gold MH, Weiss RA, Baumann L, Grekin SK, Robinson DM, Kempers SE, Alvandi N, Weng E, Berk DR, Ahluwalia G. Efficacy and safety of oxymetazoline cream 1.0% for treatment of persistent facial erythema associated with rosacea: Findings from the 52-week open label REVEAL trial. J Am Acad Dermatol. 2018 Jun;78(6):1156-1163. PMID: 29409914.